tm logo

Monitor this mark

View On USPTO

EVOXAC
Live/Registered
REGISTERED AND RENEWED

on 14 Dec 2022

Last Applicant/ Owned by

COSETTE PHARMACEUTICALS, INC.

200 CROSSING BLVD

BRIDGEWATER

NJ

08807

Serial Number

75837264 filed on 01st Nov 1999

Registration Number

2579509 registered on 11th Jun 2002

in the Principal Register

Correspondent Address

Mark A. Mazza

Mark A. Mazza Eckert Seamans Cherin & Mellott, LLC

Pittsburgh, PA 15219

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

EVOXAC

Pharmaceutical preparations for treatment of Sjogren's syndrome and/or Xerosis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for treatment of Sjogren's syndrome and/or Xerosis

First Use Date in General

29th Feb 2000

First Use Date in Commerce

29th Feb 2000

Mark Details

Serial Number

No 75837264

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 500879-00052

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
16th Oct 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
25th Jun 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
25th Jun 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Jun 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Dec 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
14th Dec 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
14th Dec 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
14th Dec 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Jun 2022TEAS SECTION 8 & 9 RECEIVED
18th Feb 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED